Lv52
832 积分 2024-05-13 加入
BCL-2 inhibition in haematological malignancies: Clinical application and complications
5小时前
已完结
Accelerating the integration of China into the global development of innovative anticancer drugs
7小时前
已完结
China overtakes United States on contribution to research in Nature Index
1天前
已完结
Trends in clinical development for PD-1/PD-L1 inhibitors
1天前
已完结
Innovation in the Chinese pharmaceutical industry
1天前
已完结
Chinese innovative drug R&D trends in 2024
1天前
已完结
Artificial intelligence in drug development
1天前
已完结
Trends in innovative drug development in China
7天前
已完结
Navigating the changing landscape of BTK-targeted therapies for B cell lymphomas and chronic lymphocytic leukaemia
8天前
已完结
Management of indolent B-cell Lymphomas: A review of approved and emerging targeted therapies
8天前
已完结
皖公网安备34019202002308
